775 Stock Overview
An investment holding company, researches, develops, manufactures, commercializes, markets, and sells health and agriculture-related products in the Asia Pacific and North America.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
CK Life Sciences Int'l., (Holdings) Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.38 |
| 52 Week High | HK$0.74 |
| 52 Week Low | HK$0.30 |
| Beta | 0.14 |
| 11 Month Change | 7.04% |
| 3 Month Change | 16.92% |
| 1 Year Change | -45.71% |
| 33 Year Change | -47.95% |
| 5 Year Change | 10.14% |
| Change since IPO | -82.33% |
Recent News & Updates
There's No Escaping CK Life Sciences Int'l., (Holdings) Inc.'s (HKG:775) Muted Revenues Despite A 32% Share Price Rise
May 03
CK Life Sciences Int'l. (Holdings)'s (HKG:775) Anemic Earnings Might Be Worse Than You Think
Apr 25Recent updates
There's No Escaping CK Life Sciences Int'l., (Holdings) Inc.'s (HKG:775) Muted Revenues Despite A 32% Share Price Rise
May 03CK Life Sciences Int'l. (Holdings)'s (HKG:775) Anemic Earnings Might Be Worse Than You Think
Apr 25CK Life Sciences Int'l. (Holdings) (HKG:775) Use Of Debt Could Be Considered Risky
Mar 26Here's Why CK Life Sciences Int'l. (Holdings) (HKG:775) Can Manage Its Debt Responsibly
Sep 27Does CK Life Sciences Int'l. (Holdings) (HKG:775) Have A Healthy Balance Sheet?
Sep 16Estimating The Intrinsic Value Of CK Life Sciences Int'l., (Holdings) Inc. (HKG:775)
Aug 21These 4 Measures Indicate That CK Life Sciences Int'l. (Holdings) (HKG:775) Is Using Debt Extensively
Apr 14CK Life Sciences Int'l., (Holdings) Inc. (HKG:775) Delivered A Weaker ROE Than Its Industry
Mar 18If You Had Bought CK Life Sciences Int'l. (Holdings) (HKG:775) Shares Five Years Ago You'd Have Earned 45% Returns
Feb 01
What Kind Of Shareholders Hold The Majority In CK Life Sciences Int'l., (Holdings) Inc.'s (HKG:775) Shares?
Jan 04CK Life Sciences Int'l. (Holdings) (HKG:775) Has A Somewhat Strained Balance Sheet
Dec 09We Wouldn't Rely On CK Life Sciences Int'l. (Holdings)'s (HKG:775) Statutory Earnings As A Guide
Nov 18Shareholder Returns
| 775 | HK Biotechs | HK Market | |
|---|---|---|---|
| 7D | 5.6% | 3.3% | 9.8% |
| 1Y | -45.7% | -15.5% | 12.9% |
Return vs Industry: 775 underperformed the Hong Kong Biotechs industry which returned -15.5% over the past year.
Return vs Market: 775 underperformed the Hong Kong Market which returned 12.9% over the past year.
Price Volatility
| 775 volatility | |
|---|---|
| 775 Average Weekly Movement | 5.6% |
| Biotechs Industry Average Movement | 7.1% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in HK Market | 13.6% |
| 10% least volatile stocks in HK Market | 3.5% |
Stable Share Price: 775 has not had significant price volatility in the past 3 months.
Volatility Over Time: 775's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 1,968 | Alan Abel Yu | www.ck-lifesciences.com |
CK Life Sciences Int'l., (Holdings) Inc., an investment holding company, researches, develops, manufactures, commercializes, markets, and sells health and agriculture-related products in the Asia Pacific and North America. It manufactures and markets plant protection products and soluble fertilizers; manufactures, blends, distributes, and sells fertilizers, pesticides, and related agricultural products; manufactures and distributes horticultural products for the home gardening market; and produces non-sterile prescription and over-the-counter medicines. The company is also involved in the contract manufacturing of complementary healthcare medicines, pharmaceutical products, and cosmetics; licensing of registration activities and the importation of finished agricultural goods; holding of land and buildings; financing activities; investment in financial instruments and vineyards; trading of biotechnology products and nutritional supplements; and manufacturing, wholesaling, retailing, and distribution of nutraceutical products.
CK Life Sciences Int'l., (Holdings) Inc. Fundamentals Summary
| 775 fundamental statistics | |
|---|---|
| Market cap | HK$3.65b |
| Earnings (TTM) | -HK$18.66m |
| Revenue (TTM) | HK$5.38b |
0.7x
P/S Ratio-195.7x
P/E RatioIs 775 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 775 income statement (TTM) | |
|---|---|
| Revenue | HK$5.38b |
| Cost of Revenue | HK$3.74b |
| Gross Profit | HK$1.64b |
| Other Expenses | HK$1.66b |
| Earnings | -HK$18.66m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0019 |
| Gross Margin | 30.43% |
| Net Profit Margin | -0.35% |
| Debt/Equity Ratio | 136.3% |
How did 775 perform over the long term?
See historical performance and comparison